Statements (125)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:customerFeedback |
positive feedback.
|
| gptkbp:hasAbstract |
treatment of tumors.
This invention relates to a method for treating cancer. |
| gptkbp:hasAccessibilityFeatures |
improves quality of life.
|
| gptkbp:hasAffiliation |
with chemotherapy.
|
| gptkbp:hasAssignee |
Pharmaceutical_Company_Inc.
|
| gptkbp:hasCampus |
awareness campaigns ongoing.
|
| gptkbp:hasCapacity |
patient rights protected.
|
| gptkbp:hasClaim |
20 claims.
|
| gptkbp:hasCollaborationsWith |
collaborative research ongoing.
with_Research_Institute. |
| gptkbp:hasCompetitors |
several competitors.
|
| gptkbp:hasDepartment |
breast cancer.
|
| gptkbp:hasDescription |
randomized controlled trial.
|
| gptkbp:hasEvents |
mandatory reporting.
|
| gptkbp:hasFacility |
ethical considerations addressed.
|
| gptkbp:hasFeature |
cost-effective.
included in guidelines. |
| gptkbp:hasFieldOfUse |
oncology.
|
| gptkbp:hasFilingDate |
2004-02-06
|
| gptkbp:hasFilm |
nausea.
|
| gptkbp:hasFunding |
funded by grants.
National_Institutes_of_Health. |
| gptkbp:hasHistoricalSignificance |
builds health partnerships.
conducts health surveillance. influences health policy. positive impact. promotes health sustainability. supports health systems research. |
| gptkbp:hasHistory |
advocates for health equity.
awarded health grants. conducts health data analysis. conducts health outreach. conducts health technology assessments. drives health innovation. encourages health collaboration. encourages health networking. fosters health collaboration. implements health interventions. improves access to care. improves health accessibility. improves health outcomes. improves healthcare quality. integrates health services. offers health support. promotes health diversity. promotes health. provides health education. provides health resources. receives health funding. supports health advocacy. supports health inclusion. supports health research. tracks health metrics. training programs available. |
| gptkbp:hasInternationalClassification |
A61K 31/00.
|
| gptkbp:hasInventor |
gptkb:John_Doe
Jane_Smith. |
| gptkbp:hasLegalEvent |
maintenance fee paid.
|
| gptkbp:hasLegalStatus |
Active.
substantive examination. FDA_approved. |
| gptkbp:hasLocalCuisine |
Phase II.
NCT01234567. |
| gptkbp:hasMember |
with_Biotech_Company.
|
| gptkbp:hasMerchandise |
inhibits cell proliferation.
|
| gptkbp:hasMission |
ensures patient safety.
|
| gptkbp:hasOccupation |
compliant with regulations.
approved by ethics committee. community programs available. approved_by_FDA. |
| gptkbp:hasPartnershipsWith |
commercialized.
survivorship care available. |
| gptkbp:hasPatentNumber |
6,789,988
|
| gptkbp:hasPerformance |
ongoing.
|
| gptkbp:hasPerformedAt |
oral.
|
| gptkbp:hasPopulation |
adult patients.
|
| gptkbp:hasPriorityDate |
2004-09-14
2003-02-06 2024-09-14. |
| gptkbp:hasPrograms |
demonstrated efficacy.
acceptable safety. part of global initiatives. patient information available. support programs available. |
| gptkbp:hasPublications |
significant impact.
granted patent. published_in_Journal_of_Oncology. |
| gptkbp:hasRecognition |
p < 0.05.
|
| gptkbp:hasRelatedPatent |
utility patent.
US_6,789,987. |
| gptkbp:hasResearchFocus |
cancer therapies.
|
| gptkbp:hasResearchInterest |
ongoing studies.
biomedical research. positive results. therapeutic agents. University_of_Science. |
| gptkbp:hasSpecialty |
protected by patent.
overall survival. high adherence. influences public health policy. |
| gptkbp:hasTechnicalField |
pharmaceutical compositions.
|
| gptkbp:hasTechnology |
improved efficacy.
|
| gptkbp:hasTitle |
Method for treating cancer using a combination of agents
|
| gptkbp:hasVariants |
innovative treatment.
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,988 U87
|
| gptkbp:inventiveStep |
novel combination of agents.
|
| gptkbp:isAssignedTo |
Pharmaceutical_Company_Inc.
|
| gptkbp:isCitedBy |
10 citations.
US_7,123,456. |
| gptkbp:isFiledIn |
gptkb:United_States
|
| gptkbp:isFiledUnder |
35 U.S.C. 111.
|
| gptkbp:isMarketedAs |
accessible to patients.
|
| gptkbp:isPartOf |
patent family.
|
| gptkbp:isPublishedIn |
gptkb:US_2004/0199999_A1
|
| gptkbp:isReferencedBy |
US_8,765,432.
|
| gptkbp:isRelatedTo |
cancer treatment
|
| gptkbp:isSubjectTo |
patent law.
|
| gptkbp:market |
2025-01-01.
pharmaceutical market. approved for market. available worldwide. |
| gptkbp:relatedPatent |
adheres to research ethics.
|
| gptkbp:route |
systemic.
|